We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

90 hedge funds and large institutions have $148M invested in CTI BioPharma Corp. (DE) Common Stock in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

548% more call options, than puts

Call options by funds: $2.61M | Put options by funds: $402K

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

47% more capital invested

Capital invested by funds: $100M → $148M (+$47M)

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

6% more funds holding

Funds holding: 85 → 90 (+5)

Holders
90
Holders Change
+5
Holders Change %
+5.88%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
32
Reduced
13
Closed
16
Calls
$2.61M
Puts
$402K
Net Calls
+$2.2M
Net Calls Change
+$441K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$11.2M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.16M
3
RCM
RA Capital Management
Massachusetts
+$5.78M
4
DCM
DAFNA Capital Management
California
+$3.29M
5
TC
TFS Capital
Pennsylvania
+$3M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$978K
2
Jane Street
Jane Street
New York
-$901K
3
Deutsche Bank
Deutsche Bank
Germany
-$703K
4
HCM
Highbridge Capital Management
New York
-$311K
5
EEG
E.E. Geduld
-$97K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1M +$75.1K +3,248 +8%
WT
27
Washington Trust
Rhode Island
$969K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$877K -$703K -30,424 -45%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$830K +$813K +35,154 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$813K – – –
TCT
31
TIAA CREF Trust
Missouri
$699K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$659K +$72.7K +3,146 +13%
Barclays
33
Barclays
United Kingdom
$459K +$11.7K +508 +2%
Charles Schwab
34
Charles Schwab
California
$451K – – –
Swiss National Bank
35
Swiss National Bank
Switzerland
$450K – – –
UCFA
36
United Capital Financial Advisors
Texas
$355K – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$344K -$42.9K -1,855 -11%
AQR Capital Management
38
AQR Capital Management
Connecticut
$282K – – –
VOYA Investment Management
39
VOYA Investment Management
Georgia
$271K – – –
NFA
40
Nationwide Fund Advisors
Ohio
$265K +$19.8K +855 +8%
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$263K +$258K +11,150 New
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$262K – – –
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$247K +$7.51K +325 +3%
CS
44
Credit Suisse
Switzerland
$236K +$53.2K +2,300 +30%
VKH
45
Virtu KCG Holdings
New York
$235K +$7.98K +345 +4%
AIG
46
American International Group
New York
$224K +$15.3K +662 +8%
UBS AM
47
UBS AM
Illinois
$222K – – –
CCMH
48
Cornerstone Capital Management Holdings
New York
$221K +$217K +9,380 New
BA
49
BlackRock Advisors
Delaware
$208K +$4.32K +187 +2%
FHC
50
First Heartland Consultants
Missouri
$176K – – –
1
2
3 4 5

CTIC Hedge Fund Activity: Q4 2014 in Review

90 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q4 2014, worth a combined $148M — up 47% from $100M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CTIC positions and 16 closed out — a net gain of 6 holders — while 32 added to existing stakes and 13 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $11.2M. The largest seller was Renaissance Technologies, cutting an estimated $978K.

  • 90 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q4 2014, up from 85 in Q3 2014.
  • Funds reported $148M of CTI BioPharma Corp. (DE) Common Stock stock for Q4 2014, up 47% quarter-over-quarter.
  • 22 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q4 2014 and 16 closed out, a net change of +6 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q4 2014 was Eagle Asset Management, an estimated $11.2M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q4 2014 was Renaissance Technologies, an estimated $978K sold.

Based on aggregated 13F filings for Q4 2014.